共 19 条
[1]
Markowska J., Epidemiologia raka endometrium, Kliniczna Perinatologia i Ginekologia, 6, pp. 54-64, (1993)
[2]
Tkeshelashvili V.T., Bokhman J.V., Kuznetzov V.V., Et al., Geographic peculiarities of endometrial and cervical cancer incidence in five continents, Eur J Gynaecol Oncol, 2, pp. 89-94, (1993)
[3]
Zatonski W., Tyczynski J., Nowotwory Zlosliwe w Polsce w 1993 Roku, (1996)
[4]
Markowska J., Rak BΠony Sluzowej Trzonu Macicy, (1998)
[5]
Wronkowski Z., Zwierko M., Chmielarczyk, Epidemiologia nowotworow zlosliwych miednicy, Nowotwory, 45, pp. 26-32, (1995)
[6]
Borazjani G., Twiggs L.B., Leung B.S., Et al., Prognostic significance of steroid receptors measured in primary metastatic and recurrent endometrial carcinoma, Am J Obstet Gynecol, 161, pp. 1253-1257, (1989)
[7]
Christopherson W.M., Conelly P.J., Alberbasky R.C., Caecinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and stage I disease, Cancer, 51, pp. 1705-1709, (1983)
[8]
Schapira D.V., Kumar N.B., Lyman G.H., Et al., Upper-body fat distribution and endometrial cancer risk, JAMA, 266, pp. 1808-1811, (1991)
[9]
Swanson C.A., Potischman N., Wilbanks G.D., Et al., Relation of endometrial cancer risk to past and contemporary body size and body fat distribution, Cancer Epidemiol Biomarkers Prev, 2, pp. 321-327, (1993)
[10]
Finan M.A., Hoffman M.S., Chambers R., Et al., Body mass predicts the survival of patients with new International Federation of Gynecology and Obstetrics Stage IB1 and IB2 cervical carcinoma treated with radical hysterectomy, Cancer, 83, pp. 98-102, (1998)